Dimension Capital's $800M third fund shows the intersection of science and compute is booming TechCrunchInvestors bet on AI drug discovery despite approval gap Financial TimesDimension restocks with $800M to capitalize on AI’s ‘rapid ascent’ BioPharma DiveDimension Capital raises $800 million third fund to back science and computing startups Межа. Новини України.
Key Highlights
Dimension Capital's $800M third fund shows the intersection of science and compute is booming TechCrunchInvestors bet on AI drug discovery despite approval gap Financial TimesDimension restocks with $800M to capitalize on AI’s ‘rapid ascent’ BioPharma DiveDimension Capital raises $800 million third fund to back science and computing startups Межа. Новини України.
Frequently Asked Questions
What is this about?
Dimension Capital's $800M third fund shows the intersection of science and compute is booming TechCrunchInvestors bet on AI drug discovery despite approval gap Financial TimesDimension restocks with $800M to capitalize on AI’s…